Seoul St. Mary's Hospital Catholic Blood Hospital Implements CAR-T Cell Therapy to Selectively Kill Cancer Cells
Novartis Cell Immunotherapy 'Kymriah' Treatment System Fully Established
[Asia Economy Reporter Lee Gwan-ju] The Catholic Hematology Hospital at Seoul St. Mary's Hospital announced on the 30th that it will officially begin treatment using Novartis's cell immunotherapy drug 'Kymriah.'
Kymriah can be used for patients with diffuse large B-cell lymphoma (DLBCL) who have shown relapse or refractory response after two or more treatments, and for patients aged 25 or younger with B-cell acute lymphoblastic leukemia (ALL).
Seoul St. Mary's Hospital was the first in Korea to establish a cell processing facility GMP, an essential facility for cell therapy within a university institution, and has conducted various immune cell therapy and stem cell research utilizing this facility. CAR-T is one aspect of such cell therapy, and it is expected to produce high-quality CAR-T cell therapies.
CAR-T is a type of advanced cell therapy that enhances the tumor-killing ability of T immune cells by binding them to a protein called chimeric antigen receptor (CAR), enabling more powerful destruction of tumor cells.
In Korea, since last year, CAR-T clinical trials targeting lymphoma and multiple myeloma patients have been introduced mainly in large hospitals, and recently, the full-scale commercialization process has been underway.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Professor Eom Ki-sung, head of the Advanced Regenerative Medicine Committee at the Catholic Hematology Hospital and a hematology specialist, stated, “The Catholic Hematology Hospital has abundant clinical experience related to cell therapy based on hematopoietic stem cell transplantation, and has successfully provided CAR-T therapy conducted through clinical research. We are very hopeful as we establish a treatment system using Kymriah to offer the latest treatments to domestic patients.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
